These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23168281)

  • 1. Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: endocrine aspects.
    Aguer C; Harper ME
    Best Pract Res Clin Endocrinol Metab; 2012 Dec; 26(6):805-19. PubMed ID: 23168281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity.
    O'Neill HM; Holloway GP; Steinberg GR
    Mol Cell Endocrinol; 2013 Feb; 366(2):135-51. PubMed ID: 22750049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes mellitus and skeletal muscle metabolic function.
    Phielix E; Mensink M
    Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging.
    Toledo FG; Goodpaster BH
    Mol Cell Endocrinol; 2013 Oct; 379(1-2):30-4. PubMed ID: 23792186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes.
    Devarshi PP; McNabney SM; Henagan TM
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction in type 2 diabetes and obesity.
    Højlund K; Mogensen M; Sahlin K; Beck-Nielsen H
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):713-31, x. PubMed ID: 18775360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high-fat overfeeding on mitochondrial function, glucose and fat metabolism, and adipokine levels in low-birth-weight subjects.
    Brøns C; Jacobsen S; Hiscock N; White A; Nilsson E; Dunger D; Astrup A; Quistorff B; Vaag A
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E43-51. PubMed ID: 21917634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adipokines in the control of energy metabolism: focus on adiponectin.
    Lafontan M; Viguerie N
    Curr Opin Pharmacol; 2006 Dec; 6(6):580-5. PubMed ID: 16973420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus.
    Blaak EE
    Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscular mitochondrial dysfunction and type 2 diabetes mellitus.
    Schrauwen-Hinderling VB; Roden M; Kooi ME; Hesselink MK; Schrauwen P
    Curr Opin Clin Nutr Metab Care; 2007 Nov; 10(6):698-703. PubMed ID: 18089950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes.
    De Feyter HM; Lenaers E; Houten SM; Schrauwen P; Hesselink MK; Wanders RJ; Nicolay K; Prompers JJ
    FASEB J; 2008 Nov; 22(11):3947-55. PubMed ID: 18653763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between adipokines, diet and exercise on muscle insulin sensitivity.
    Stefanyk LE; Dyck DJ
    Curr Opin Clin Nutr Metab Care; 2010 May; 13(3):255-9. PubMed ID: 20216410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue as an endocrine organ.
    Ahima RS
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():242S-249S. PubMed ID: 17021375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice.
    Bonnard C; Durand A; Peyrol S; Chanseaume E; Chauvin MA; Morio B; Vidal H; Rieusset J
    J Clin Invest; 2008 Feb; 118(2):789-800. PubMed ID: 18188455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
    Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
    Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both linoleic and α-linolenic acid prevent insulin resistance but have divergent impacts on skeletal muscle mitochondrial bioenergetics in obese Zucker rats.
    Matravadia S; Herbst EA; Jain SS; Mutch DM; Holloway GP
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(1):E102-14. PubMed ID: 24844257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of mitochondrial uncoupling in skeletal muscle in the development and treatment of obesity.
    Thrush AB; Dent R; McPherson R; Harper ME
    FEBS J; 2013 Oct; 280(20):5015-29. PubMed ID: 23786211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin corrects high-fat diet-induced disturbances in muscle metabolomic profile and whole-body glucose homeostasis.
    Liu Y; Turdi S; Park T; Morris NJ; Deshaies Y; Xu A; Sweeney G
    Diabetes; 2013 Mar; 62(3):743-52. PubMed ID: 23238294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.